These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 39301743)
1. Oral HIV pre-exposure prophylaxis use and resistance-associated mutations among men who have sex with men and transgender persons newly diagnosed with HIV in the Netherlands: results from the ATHENA cohort, 2018 to 2022. Jongen VW; Bezemer D; van Sighem A; Boyd A; Rokx C; Grintjes K; Cents-Bosma A; Op de Coul E; van Benthem B; Wensing A; Wit FW; van der Valk M; Euro Surveill; 2024 Sep; 29(38):. PubMed ID: 39301743 [TBL] [Abstract][Full Text] [Related]
2. Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections. Pagkas-Bather J; Khosropour CM; Golden MR; Thibault C; Dombrowski JC J Acquir Immune Defic Syndr; 2021 Jun; 87(2):769-775. PubMed ID: 33538527 [TBL] [Abstract][Full Text] [Related]
3. Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy: Modeling from antiretroviral resistance cohort analysis (ARCA) national database. Rossotti R; Borghi V; Callegaro AP; Micheli V; Bruzzone B; Colao G; Gismondo MR; Vicenti I; Penco G; Zazzi M; Rusconi S J Clin Virol; 2016 Oct; 83():48-53. PubMed ID: 27591555 [TBL] [Abstract][Full Text] [Related]
4. High risk and low uptake of pre-exposure prophylaxis to prevent HIV acquisition in a national online sample of transgender men who have sex with men in the United States. Reisner SL; Moore CS; Asquith A; Pardee DJ; Sarvet A; Mayer G; Mayer KH J Int AIDS Soc; 2019 Sep; 22(9):e25391. PubMed ID: 31536171 [TBL] [Abstract][Full Text] [Related]
5. Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort. van den Elshout MAM; Wijstma ES; Boyd A; Jongen VW; Coyer L; Anderson PL; Davidovich U; de Vries HJC; Prins M; Schim van der Loeff MF; Hoornenborg E; PLoS Med; 2024 May; 21(5):e1004328. PubMed ID: 38718068 [TBL] [Abstract][Full Text] [Related]
6. PrEP interest and HIV-1 incidence among MSM and transgender women in coastal Kenya. Kimani M; van der Elst EM; Chiro O; Oduor C; Wahome E; Kazungu W; Shally M; Rinke de Wit TF; Graham SM; Operario D; Sanders EJ J Int AIDS Soc; 2019 Jun; 22(6):e25323. PubMed ID: 31194291 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens. Ramautarsing RA; Meksena R; Sungsing T; Chinbunchorn T; Sangprasert T; Fungfoosri O; Meekrua D; Sumalu S; Pasansai T; Bunainso W; Wongsri T; Mainoy N; Colby D; Avery M; Mills S; Vannakit R; Phanuphak P; Phanuphak N J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25540. PubMed ID: 32602660 [TBL] [Abstract][Full Text] [Related]
8. Acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in Northern Thailand. Yang D; Chariyalertsak C; Wongthanee A; Kawichai S; Yotruean K; Saokhieo P; Guadamuz T; Suwanvanichkij V; Beyrer C; Chariyalertsak S PLoS One; 2013; 8(10):e76650. PubMed ID: 24116132 [TBL] [Abstract][Full Text] [Related]
9. HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project. Sullivan PS; Phaswana-Mafuya N; Baral SD; Valencia R; Zahn R; Dominguez K; Yah CS; Jones J; Kgatitswe LB; McNaghten AD; Siegler AJ; Sanchez TH; Bekker LG J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25591. PubMed ID: 33000918 [TBL] [Abstract][Full Text] [Related]
10. The Pre-Exposure Prophylaxis Cascade in At-Risk Transgender Men Who Have Sex with Men in the United States. Reisner SL; Moore CS; Asquith A; Pardee DJ; Mayer KH LGBT Health; 2021; 8(2):116-124. PubMed ID: 33567245 [No Abstract] [Full Text] [Related]
11. High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project. Hoagland B; Moreira RI; De Boni RB; Kallas EG; Madruga JV; Vasconcelos R; Goulart S; Torres TS; Marins LMS; Anderson PL; Luz PM; Costa Leite ID; Liu AY; Veloso VG; Grinsztejn B; J Int AIDS Soc; 2017 Apr; 20(1):21472. PubMed ID: 28418232 [TBL] [Abstract][Full Text] [Related]
12. Pre-exposure prophylaxis among men who have sex with men in the Amsterdam Cohort Studies: Use, eligibility, and intention to use. Coyer L; van Bilsen W; Bil J; Davidovich U; Hoornenborg E; Prins M; Matser A PLoS One; 2018; 13(10):e0205663. PubMed ID: 30312336 [TBL] [Abstract][Full Text] [Related]
13. Factors Associated with PrEP Support and Disclosure Among YMSM and Transgender Individuals Assigned Male at Birth in Chicago. Phillips G; Raman A; Felt D; Han Y; Mustanski B AIDS Behav; 2019 Oct; 23(10):2749-2760. PubMed ID: 31228025 [TBL] [Abstract][Full Text] [Related]
14. Men who have sex with men more often chose daily than event-driven use of pre-exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam. Hoornenborg E; Achterbergh RC; van der Loeff MFS; Davidovich U; van der Helm JJ; Hogewoning A; van Duijnhoven YT; Sonder GJ; de Vries HJ; Prins M; J Int AIDS Soc; 2018 Mar; 21(3):e25105. PubMed ID: 29603900 [TBL] [Abstract][Full Text] [Related]
15. HIV Prevention Method Preferences Within Sexual Partnerships Reported by HIV-Negative MSM and TW in Tijuana, Mexico. Pines HA; Patrick R; Smith DM; Harvey-Vera A; Blumenthal JS; Rangel G; Semple SJ; Patterson TL AIDS Behav; 2020 Mar; 24(3):839-846. PubMed ID: 30945030 [TBL] [Abstract][Full Text] [Related]
16. Bacterial sexually transmitted infections among men who have sex with men and transgender women using oral pre-exposure prophylaxis in Latin America (ImPrEP): a secondary analysis of a prospective, open-label, multicentre study. Torres Silva MS; Torres TS; Coutinho C; Ismério Moreira R; da Costa Leite I; Cunha M; da Costa Leite PHA; Cáceres CF; Vega-Ramírez H; Konda KA; Guanira J; Valdez Madruga J; Wagner Cardoso S; Benedetti M; Pimenta MC; Hoagland B; Grinsztejn B; Gonçalves Veloso V; Lancet HIV; 2024 Oct; 11(10):e670-e679. PubMed ID: 39243787 [TBL] [Abstract][Full Text] [Related]
17. Provider attitudes toward oral preexposure prophylaxis for HIV prevention among high-risk men who have sex with men in Lima, Peru. Tang EC; Sobieszczyk ME; Shu E; Gonzales P; Sanchez J; Lama JR AIDS Res Hum Retroviruses; 2014 May; 30(5):416-24. PubMed ID: 24319983 [TBL] [Abstract][Full Text] [Related]
18. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC; Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284 [TBL] [Abstract][Full Text] [Related]
19. Factors associated with PrEP use in a community sample of African American men who have sex with men (MSM) and transgender women (TGW) in the United States Midwest. Kelly JA; Walsh JL; DiFranceisco WJ; Amirkhanian YA; Quinn K; Brown KD; Pearson B; Foster J; Rosado AN; McAuliffe TL AIDS Care; 2024 Jul; 36(sup1):101-108. PubMed ID: 38311890 [TBL] [Abstract][Full Text] [Related]
20. Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study. Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25495. PubMed ID: 32562365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]